Recent 8-K filings for RVP

• August 14, 2026, 5:19 PM ET earnings materiality 0.70 negative item 8.01item 9.01

  Retractable Technologies Q2 2026 sales drop 31% to $7.2M; operating loss $5.1M

  Q2 2026 net sales $7.2M vs $10.4M in Q2 2025; operating loss $5.1M flat YoY.

• May 15, 2026, 4:41 PM ET earnings materiality 0.80 negative item 8.01item 9.01

  Retractable Technologies Q1 net sales $7.2M (down 13% YoY); operating loss widens to $6.2M

  Net sales $7.2M for Q1 2026, down from $8.3M in Q1 2025; net loss $4.2M.

• April 10, 2026, 7:59 PM ET other material materiality 0.60 negative item 8.01item 9.01

  Retractable Technologies cuts workforce ~16% to save $2.2M annually amid tariff concerns

  Reduced workforce by ~16%; expects $2.2M annual savings (13% of total workforce costs).

• March 27, 2026, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Tech 2025 revenue up 15.8% to $38.3M; operating loss $21.2M; tariff headwinds

  Revenue $38.3M (+15.8% YoY); domestic +9.7%, international +64%.

• November 14, 2025, 6:59 PM ET earnings materiality 0.70 neutral item 8.01item 9.01

  Retractable Q3 net sales $10.1M, operating loss $3.7M; receives Vizient designation

  Q3 net sales $10.1M (down from $10.3M YoY); operating loss $3.7M vs $5.1M loss last year.

• August 14, 2025, 7:59 PM ET earnings materiality 0.65 neutral item 8.01item 9.01

  Retractable Technologies Q2 net sales up 73% to $10.4M, operating loss narrows to $5.1M

  Net sales $10.4M in Q2 2025 (+73% YoY); operating loss narrowed to $5.1M from $5.8M.

• July 23, 2025, 7:59 PM ET other material materiality 0.60 negative item 8.01item 9.01

  Retractable Tech reduces workforce 12.4%, expects $1.6M annual savings

  Workforce reduction of ~12.4% in manufacturing and support roles; one-time separation payments of ~$56k.

• May 21, 2025, 7:59 PM ET litigation materiality 0.70 positive item 8.01

  Retractable Technologies settles lawsuit against Locke Lord for $1.9M

  Settlement resolves all claims in Case DC-19-17946 against Locke Lord LLP in Dallas County court.

• May 15, 2025, 7:59 PM ET earnings materiality 0.65 negative item 5.07item 8.01item 9.01

  Retractable Q1 net sales $8.3M; operating loss widens to $4.7M on $1.5M tariffs

  Total net sales $8.3M vs $7.6M YoY; operating loss $4.7M vs $3.0M YoY.

• March 28, 2025, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Technologies reports 2024 revenue down 24% to $33.0M; operating loss widens to $21.1M

  Revenue decreased 24.2% to $33.0M from $43.5M; domestic down 15.1%, international down 59.1%.

• January 14, 2025, 6:59 PM ET other materiality 0.60 neutral item 8.01item 9.01

  Retractable Technologies withdraws tariff complaint; engineers adapt equipment to reduce imports

  Withdrew complaint in US Court of International Trade over 100% tariff on syringes/needles from China; case dismissed Jan 8, 2025.

• November 14, 2024, 6:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Technologies Q3 2024 operating loss of $5.1M widens from $936K; tariffs and lawsuit pending

  Net sales $10.3M flat YoY; operating loss of $5.1M vs $936K loss last year.

• September 30, 2024, 7:59 PM ET other material materiality 0.90 negative item 8.01item 9.01

  USTR sets 100% tariff on Chinese syringes; Retractable files suit; declares preferred dividend

  USTR finalized 100% tariff on Chinese syringes/needles effective Sept 27, 2024; Retractable sourced 91% from China in H1 2024.

• August 14, 2024, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Tech Q2 net sales $6.0M, operating loss $5.8M; tariff risk on China imports

  Q2 net sales $6.0M, down 25% YoY; operating loss $5.8M vs $5.0M loss.

• May 15, 2024, 7:59 PM ET earnings materiality 0.70 negative item 5.07item 8.01item 9.01 ◈ Shareholder Votes

  Retractable Technologies Q1 net sales fall to $7.6M; operating loss widens to $3.0M

  Net sales $7.6M, down 31% from $11.0M in Q1 2023 due to lack of COVID vaccine syringe sales.

• March 29, 2024, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Technologies reports 2023 revenue down 54% to $43.6M, operating loss of $11.5M

  Revenue $43.6M, down 54% YoY; domestic down 33.7%, international down 78.9%.

• November 14, 2023, 6:59 PM ET earnings materiality 0.70 negative item 8.01item 9.01

  Retractable Tech Q3 revenue drops 55% to $10.3M; operating loss widens to $936K

  Net sales fell to $10.3M in Q3 2023 from $23.1M in Q3 2022, a 55% decline; nine-month sales $29.3M vs $82.1M.

• August 14, 2023, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Technologies Q2 net sales $8.0M, operating loss $5.0M vs $14.3M sales and $2.1M loss last year

  Q2 net sales $8.0M, down 44% from $14.3M; operating loss $5.0M vs $2.1M loss in prior year.

• May 16, 2023, 7:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Q1 2023 sales down 75% to $11.0M; operating loss of $2.7M vs $9.7M profit a year ago

  Total net sales $11.0M for Q1 2023, vs $44.7M in Q1 2022; no U.S. government syringe orders.

• April 3, 2023, 7:59 PM ET earnings materiality 0.80 negative item 8.01item 9.01

  Retractable Technologies 2022 revenue drops 49.7% to $94.8M; net income falls to $5.1M

  Revenue $94.8M, down 49.7% YoY; domestic sales fell 68.8%, international up 105%.

• March 28, 2023, 7:59 PM ET other material materiality 0.60 negative item 8.01item 9.01

  Retractable Technologies cuts workforce 22%, expects $1.7M annual savings

  Workforce reduced by approximately 22%, mainly in production, operations, and logistics.

• December 29, 2022, 6:59 PM ET other material materiality 0.65 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  Retractable Technologies repurchases 3M shares at $1.60/share in private transaction with BML Investment Partners

  Agreed to repurchase 3M shares from BML Investment Partners at $1.60/share, an 8% discount to $1.74 close on Dec 22, 2022.

• December 19, 2022, 6:59 PM ET other material materiality 0.75 negative item 5.02item 8.01item 9.01

  Retractable Tech terminates 1.35M unvested options; reports stock price anomalies to SEC

  Board terminated unvested option awards at $13.00/share to Shaw, Larios, and Fort III covering 1,350,000 shares.

• November 14, 2022, 6:59 PM ET earnings materiality 0.75 negative item 8.01item 9.01

  Retractable Tech Q3 2022: operating loss $691k, net sales $23.1M, down 36% YoY

  Operating loss of $691k in Q3 2022 vs income of $8.0M in Q3 2021.

• August 15, 2022, 7:59 PM ET earnings materiality 0.70 negative item 8.01item 9.01

  Retractable Tech Q2 operating loss $2.1M; revenue $14.3M, down 66% YoY

  Operating loss of $2.1M in Q2 2022 vs operating income of $12.7M in Q2 2021.

• May 17, 2022, 7:59 PM ET earnings materiality 0.65 negative item 8.01item 9.01

  Retractable Technologies Q1 operating income falls to $9.7M from $23.4M YoY on lower U.S. government sales

  Operating income $9.7M vs $23.4M in Q1 2021; net sales $44.7M vs $50.1M.

• April 1, 2022, 7:59 PM ET earnings materiality 0.75 positive item 8.01item 9.01

  Retractable Technologies reports 2021 revenues up 130% to $188.4M, operating income triples to $72.6M

  2021 revenues $188.4M vs $81.9M prior year (+130.1%); unit sales up 116.9%.

• November 18, 2021, 6:59 PM ET earnings materiality 0.75 positive item 1.01item 8.01item 9.01

  Retractable posts $44.1M op income for 9 months, amends license deal with CEO

  Operating income of $44.1M for nine months ended Sep 30, 2021, up from $11.8M in prior year.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.90 · Median 0.60 · Most common event earnings

3 positive 24 negative 23 neutral

source · RVP on sec.gov